Observatory of Pediatric Severe Communautary Bacterial Infections
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Hospitalized Children
- 发起方
- Association Clinique Thérapeutique Infantile du val de Marne
- 入组人数
- 3000
- 试验地点
- 1
- 主要终点
- medical characterisation of children hospitalized for severe communautary bacterial infection case
- 状态
- 招募中
- 最后更新
- 上个月
概览
简要总结
Severe bacterial infections are a worldwide scourge. However, the epidemiology of this type of infection varies over time. It is therefore essential to monitor them in order to prevent them more effectively. At this time, in France, no monitoring exists for this kind of infections.
详细描述
The main aim of this study is to assess the number of cases and describe the clinical, biological and microbiological characteristics of these cases of severe communautary invasive bacterial infections in children hospitalized in pediatric intensive care units. In addition, the management of these hospitalized children will be described.
研究者
入排标准
入选标准
- •Age \<18 years (only hospitalized children)
- •Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment).
排除标准
- •Refusal by one of the parents or by Child in understanding age
- •Nosocomial infection
结局指标
主要结局
medical characterisation of children hospitalized for severe communautary bacterial infection case
时间窗: 1 year
Assessment of clinical, biological and microbiological characteristics of hospitalized children in intensive care unit due to severe communautary bacterial infections cases
number of pediatrics cases of severe communautary bacterial infections
时间窗: 1 year
Proportion of hospitalized children in intensive care unit due to severe communautary bacterial infections
次要结局
- Type of complications(1 year)
- Identify predictive signs of severe cases in infected children.(1 year)
- treatment used during hospitalisation(1 year)
- Identify risk factors of serious infection(1 year)
- healthcare used for infected children(1 year)
- Patients outcome(1 year)
- Bacterial strain characterization(1 year)